Rotate Your Device

This site doesn't support landscape mode. Please rotate your phone to portrait.

Sunny Ommanney

Sunny Ommanney

General Partner

Los Angeles, California, United StatesVenture Capital & Private Equity
Company
Imbrium Ventures, LLC
Title
General Partner
Seniority
Partner
Department
C Suite
Location
Los Angeles, California, United States
Industry
Venture Capital & Private Equity

About

I invest at the intersection of biology, technology, and capital - backed by a career that spans molecular research, nanobiotechnology, and institutional portfolio management.My foundation began at Cornell University’s NanoScale Facility (CNF), where I worked across virology, oncology, and nanotech engineering alongside PhD researchers. That early exposure shaped how I think today: rigorous science, curiosity-driven exploration, and the belief that breakthroughs come from crossing disciplines.Before moving full-time into private equity and venture capital, I served as a Partner & Portfolio Manager at DoubleLine Capital, managing institutional strategies and working with firms ranging from JPMorgan to sovereign allocators. That experience now underpins my investment approach: disciplined underwriting, deep diligence, and a long-term orientation toward value creation.Today, as a General Partner, I focus on:🔹 Novel therapeutics (cell & gene therapy, RNA, mitochondrial biology, ra…

Experience

General Partner

Imbrium Ventures, LLC · Los Angeles, California

Present

Venture capital funding for seed and early-stage.

Advisor - Biotech

Altuva Group · Los Angeles, California

Present

A new class of public-market investment platform built to restoring trapped capital.

Portfolio Manager & Partner

DoubleLine · Los Angeles, California

Equity Research Analyst

DoubleLine Group LP · Los Angeles, California

Series C Investor - Ipo

MeiraGTx

Series a & B Investor - Ipo

Vir Biotechnology, Inc.

Series a & B Investor - Ipo

Ovid Therapeutics

Equity Research Analyst

Provident Investment Counsel · Los Angeles, California

Nanotechnology Researcher, Cornell Nanoscale Science & Technology Facility (Cnf)

Cornell University · Ithaca, New York

-Johnson Graduate School of Management – Independent Study with Professor Carl Batt. -Granted C-level cleanroom user certification in CNF’s Duffield Hall nanofabrication facility (rare for an MBA student). -Conducted hands-on research in nanoscale materials and microfabrication as part of graduate-level nanotechnology coursework. -Advised by Carl Batt, PhD, in applied nanotechnology and technology commercialization. -Combined scientific research with market analysis for emerging nanotech applications. -Worked with Professor Batt and his team of post-docs and advised on their business plan for a startup called Illuminaria.

Manager, Venture Incubation

Cornell University · Ithaca, New York

-Bridged the business school with Cornell's Life Sciences multi-disciplinary departments to enable technology transfer on campus. -Incubated a startup on campus called Novomer, which makes advanced plastic materials. -Novomer raised $6.6 million at the end of 2007. -Authored the Cornell Lifesciences Initiative to bridge the university with Cornell's MBA program to help venture capital and intellectual property licensing of technologies invented on campus.

Equity Research Associate

Lazard · New York, New York

Derivatives Manager, Fintech

Patent & License Exchange · Los Angeles, California

-Board observer. -Helped build large language models (LLM) used as fintech tools to value intellectual property. -Created the derivatives department by hiring a team of analysts. Managed 6 full-time analysts and 15 part-time Ph.D. engineers from Caltech. -Guided software engineers at Ernst & Young (our early-stage partner) through the functional design of PLX's quantitative and qualitative intangible asset management tools (Black-Scholes, DCF, and Comparables Method) and reviewed coding written in Java (implemented in C and C++). -Valued healthcare and technology intellectual property (technology, biotechnology, medical devices, pharmaceuticals, and services). -Clients included: Merck (MRK), GlaxoSmithKline (GSK), Procter & Gamble (PG), 3M (MMM), DuPont, Intuitive Surgical (ISRG), Eastman Chemical, I-Flow, Thermogenesis, and Advanced Tissue Sciences. -Our clients totaled over 500 companies. -Wrote a weekly column in The Daily Deal (www.thedeal.com) on the monetization of intellectual p…

Education

Cornell University

Master of Business Administration (MBA); Concentrations: Finance, Biotechnology

UC Santa Barbara

Bachelor of Arts (BA); Concentrations: Economics, Accounting

Find leads like Sunny

Origami finds your ideal customers across 15+ data sources with a single prompt.

Try Origami Free